Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Frei

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Drugs - Real World Outcomes|July 18, 2021
Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)Chengwen Teng, Christopher R Frei
The American Journal of Medicine|June 14, 2011
Health care-associated pneumonia: an evidence-based reviewRussell T Attridge, Christopher R Frei
Clinical Therapeutics|January 27, 2009
Pharmacokinetic/pharmacodynamic modeling to predict in vivo effectiveness of various dosing regimens of piperacillin/tazobactam and piperacillin monotherapy against gram-negative pulmonary isolates from patients managed in intensive care units in 2002Christopher R Frei, David S Burgess
Pharmacotherapy|September 17, 2005
Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulationChristopher R Frei, David S Burgess
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2012
Declining susceptibilities of gram-negative bacteria to the fluoroquinolones: effects on pharmacokinetics, pharmacodynamics, and clinical outcomesMatthew J Labreche, Christopher R Frei
American Journal of Infection Control|July 4, 2012
The United States' progress toward eliminating catheter-related bloodstream infections: incidence, mortality, and hospital length of stay from 1996 to 2008Kelly R Daniels, Christopher R Frei
The American Journal of Medicine|March 31, 2010
Health economics of use fluoroquinolones to treat patients with community-acquired pneumoniaMarcos I Restrepo, Christopher R Frei
The Journal of Antimicrobial Chemotherapy|September 16, 2005
Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamicsDavid S Burgess, Christopher R Frei
Frontiers in Public Health|December 19, 2022
Electronic cigarette or vaping use among adolescents in the United States: A call for research and legislative actionBretton Gilmore, Kelly Reveles, Christopher R Frei
Frontiers in Cellular and Infection Microbiology|June 3, 2021
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug RepurposingNatalie K Boyd, Chengwen Teng, Christopher R Frei
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Drugs - Real World Outcomes|July 18, 2021
Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)Chengwen Teng, Christopher R Frei
The American Journal of Medicine|June 14, 2011
Health care-associated pneumonia: an evidence-based reviewRussell T Attridge, Christopher R Frei
Clinical Therapeutics|January 27, 2009
Pharmacokinetic/pharmacodynamic modeling to predict in vivo effectiveness of various dosing regimens of piperacillin/tazobactam and piperacillin monotherapy against gram-negative pulmonary isolates from patients managed in intensive care units in 2002Christopher R Frei, David S Burgess
Pharmacotherapy|September 17, 2005
Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulationChristopher R Frei, David S Burgess
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2012
Declining susceptibilities of gram-negative bacteria to the fluoroquinolones: effects on pharmacokinetics, pharmacodynamics, and clinical outcomesMatthew J Labreche, Christopher R Frei
American Journal of Infection Control|July 4, 2012
The United States' progress toward eliminating catheter-related bloodstream infections: incidence, mortality, and hospital length of stay from 1996 to 2008Kelly R Daniels, Christopher R Frei
The American Journal of Medicine|March 31, 2010
Health economics of use fluoroquinolones to treat patients with community-acquired pneumoniaMarcos I Restrepo, Christopher R Frei
The Journal of Antimicrobial Chemotherapy|September 16, 2005
Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamicsDavid S Burgess, Christopher R Frei
Frontiers in Public Health|December 19, 2022
Electronic cigarette or vaping use among adolescents in the United States: A call for research and legislative actionBretton Gilmore, Kelly Reveles, Christopher R Frei
Frontiers in Cellular and Infection Microbiology|June 3, 2021
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug RepurposingNatalie K Boyd, Chengwen Teng, Christopher R Frei
Pageof 13